InvestorsHub Logo

H2R

Followers 41
Posts 2211
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Friday, 05/12/2017 12:08:03 PM

Friday, May 12, 2017 12:08:03 PM

Post# of 1570
Orphan Designation for CYTK Treatment of spinal muscular atrophy

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=516215

 
Generic Name: fast skeletal muscle troponin activator
Trade Name: N/A
Date Designated: 05/11/2017
Orphan Designation: Treatment of spinal muscular atrophy
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date: N/A
Approved Labeled Indication:
Exclusivity End Date: N/A
Sponsor: Cytokinetics, Inc.
280 East Grand Avenue
South San Francisco, California 94080
USA

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYTK News